Cello Group plc  

(Public, LON:CLL)   Watch this stock  
Find more results for Paul L. Chello
+0.10 (0.10%)
Jul 29 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 99.10 - 101.00
52 week 0.81 - 101.00
Open 99.50
Vol / Avg. 430,874.00/86,974.00
Mkt cap 85.13M*
P/E 37.57
Div/yield 1.80/2.61*
EPS 0.03*
Shares 85.13M
Beta     -
Inst. own     -
May 13, 2015
Cello Group plc Annual Shareholders Meeting (Estimated)

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -0.08% 1.34%
Operating margin 0.63% 2.48%
EBITD margin - 6.26%
Return on average assets -0.12% 1.89%
Return on average equity -0.21% 3.32%
Employees 919 -
CDP Score - -


11-13 Charterhouse Buildings
United Kingdom - Map
+44-20-78128460 (Phone)
+44-20-72535376 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company delivers professional marketing services to the global pharmaceutical and health sectors, as well as other high margin client industries. The Company also delivers technically-led insight and marketing support services to global consumer and business-to-business clients. The Company operates business through two segments, which include Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company’s pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services principally to the Company’s consumer facing clients.

Officers and directors

Mark Scott Chief Executive, Executive Director
Mark Bentley Group Finance Director, Company Secretary, Executive Director
Stephen Highley Group Corporate Development Director, Director
Allan Rich Independent Non-Executive Chairman of the Board
William Nigel David Independent Non-Executive Director
Paul Hamilton Senior Independent Non Executive Director